4.2 Article

Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

Annamaria Colao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Endocrinology & Metabolism

Somatostatin analogs as a first-line treatment in acromegaly: when is it appropriate?

Ludovica F. S. Grasso et al.

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2012)

Review Oncology

Somatostatin analogs for the treatment of neuroendocrine tumors

Michael D. Culler et al.

CANCER AND METASTASIS REVIEWS (2011)

Article Endocrinology & Metabolism

Somatostatin Receptor-Targeted Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Dik J. Kwekkeboom et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)

Article Endocrinology & Metabolism

Pathohistological classification of pituitary tumors:: 10 years of experience with the German Pituitary Tumor Registry

Wolfgang Saeger et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

JC Reubi et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)